Cardiac Patient Anesthesia: ACVAA and ACVIM Consensus

Why Cardiac Anesthesia Is a Specialty Conversation

Anesthesia is risk redistribution. A healthy patient under skilled anesthesia tolerates the controlled stress with predictable recovery. A cardiac patient — a Stage C mitral valve disease dog, a hypertrophic cardiomyopathy cat, a Doberman with dilated cardiomyopathy, or a paced patient post-implant — has narrowed margins of safety. Drug-induced changes in heart rate, preload, afterload, and contractility that a normal patient absorbs without notice can push a marginal cardiac patient into hypotension, arrhythmia, pulmonary edema, or arrest.

The board-certified specialty framework matters here. The American College of Veterinary Anesthesia and Analgesia (ACVAA) board-certifies veterinary anesthesiologists (DACVAA), and the cardiac anesthesia case mix is one of the areas where their training shows clearest benefit. The American College of Veterinary Internal Medicine – Cardiology subspecialty (DACVIM-Cardiology) provides the cardiac assessment that informs the anesthetic plan. The two specialties produce shared frameworks for managing high-risk cardiac cases, and the textbook reference (Grimm and Lamont, Veterinary Anesthesia and Analgesia, 5th ed., cardiac chapter) is built around that joint framework.

This article describes the joint framework for owners and primary veterinarians. Specific drug doses are not provided here; dosing is set by the anesthesia team based on patient-specific factors and is outside the scope of an owner-facing reference.

Pre-Anesthetic Workup for the Cardiac Patient

A cardiac patient does not arrive at the anesthesia table without a workup. The standard package:

• Recent echocardiogram by a DACVIM-Cardiology or experienced sonographer. Disease-specific staging — Stage B1/B2/C/D for mitral valve disease, ACVIM 2020 staging for hypertrophic cardiomyopathy in cats — drives the anesthetic plan.
• ECG — resting rhythm, identification of any arrhythmia that needs management before or during anesthesia.
• Thoracic radiographs for pulmonary status, particularly if there is any concern about subclinical pulmonary edema.
• Blood pressure — baseline measurement informs intra-op interpretation.
• CBC and chemistry — anemia, electrolyte derangements, and renal function affect anesthetic planning.
• NT-proBNP — selectively useful for tracking subclinical disease; see the NT-proBNP biomarker guide.

The workup may identify a patient who needs medication optimization before anesthesia — for example, a Stage B2 MVD dog who would benefit from pre-procedure pimobendan initiation, or an arrhythmic Doberman who needs rhythm management before a non-emergency procedure.

Disease-Specific Considerations

Different cardiac diseases dictate different hemodynamic goals during anesthesia:

Mitral valve disease (MVD)

Volume-overloaded left atrium and left ventricle. Goals: maintain forward flow, avoid bradycardia (which worsens regurgitation), avoid hypotension (which compromises forward stroke volume), avoid fluid overload. Patients in Stage C or D may already be on the edge — elective anesthesia is sometimes deferred until medical optimization is complete.

Hypertrophic cardiomyopathy with left ventricular outflow tract obstruction (HOCM)

The most dangerous cardiac patient under anesthesia. Hypovolemia, hypotension, tachycardia, and increased contractility all worsen the outflow obstruction, which can precipitate arrhythmia, syncope, and sudden death. The HOCM cat needs adequate preload, controlled heart rate, and afterload preservation. Ketamine alone is contraindicated in HCM with outflow obstruction because of its sympathomimetic effects. Patients on atenolol generally continue their medication through the perioperative period.

Dilated cardiomyopathy (DCM)

Reduced contractility. Goals: minimize myocardial depressants, preserve heart rate (slower contractile reserve), maintain coronary perfusion. Doberman DCM patients with concurrent ventricular arrhythmia require rhythm monitoring throughout.

Pulmonic stenosis, subaortic stenosis, and other obstructive lesions

Maintain adequate preload, avoid tachycardia that reduces diastolic filling, avoid hypotension that drops the gradient across the obstructive lesion. Brachycephalic breeds with pulmonic stenosis (English Bulldog, French Bulldog) carry the additional challenge of airway compromise.

Patients with implanted pacemakers

Electromagnetic interference (cautery) shielding considerations, pre-procedure interrogation, and continuous ECG monitoring. The pacing system protects the patient from the bradyarrhythmia, but the team still watches for arrhythmias and threshold issues. See veterinary pacemaker implantation.

Premedication: Opioid-Centric Approach

Cardiac patient premedication centers on opioid analgesia with minimal cardiovascular depression. Pure mu agonists (methadone, hydromorphone, fentanyl) provide analgesia without significant negative inotropy. Acepromazine produces vasodilation that can be useful in some MVD patients but risky in obstructive disease — its role is patient-specific. Alpha-2 agonists (dexmedetomidine, medetomidine) are powerful but produce significant bradycardia and vasoconstriction; they are used in lower doses if at all, and avoided in patients where heart rate or afterload changes are dangerous.

Anticholinergics (atropine, glycopyrrolate) are not routine in cardiac patients because the tachycardia they produce can be detrimental in MVD and HCM. They remain available for treating intra-op bradyarrhythmia.

Induction Agents

The induction agent choice depends on disease, patient stability, and team preference:

• Etomidate is the most cardiovascularly neutral induction agent and is often preferred for critically compromised cardiac patients. It minimizes blood pressure swings during induction.
• Propofol is widely used and acceptable in stable cardiac patients but produces vasodilation and modest myocardial depression — used in carefully titrated doses.
• Alfaxalone behaves somewhat similarly to propofol; team and patient-specific.
• Ketamine alone is generally avoided in HCM with outflow obstruction and in advanced DCM. It has sympathomimetic effects that can be desirable in some hypovolemic patients and dangerous in obstructive cardiomyopathy.

Many anesthesia teams use combination induction (opioid + benzodiazepine + propofol or etomidate) to reduce the dose of any single agent and smooth the hemodynamic transition.

Maintenance and Monitoring

Inhalant maintenance with isoflurane or sevoflurane is standard. Total intravenous anesthesia (TIVA) with continuous propofol or fentanyl infusion is an alternative for selected cases. The principle is using the lowest concentration that maintains adequate anesthetic depth.

Monitoring is intensive. The minimum cardiac anesthesia monitoring stack:

• Continuous ECG with rhythm analysis
• Direct (arterial line) or indirect (Doppler, oscillometric) blood pressure
• Continuous pulse oximetry
• End-tidal CO2 (capnography) and inhalant concentration
• Body temperature with active warming as needed
• Frequent manual checks of pulse quality, mucous membrane color, capillary refill

Intra-op fluid therapy is more conservative than in healthy patients. Crystalloid rates are reduced; colloids are used selectively. Vasopressor support (dobutamine for inotropy, ephedrine or phenylephrine for vasoconstriction depending on physiology) is anticipated rather than reactive.

Regional and Local Techniques

Multimodal anesthesia using local and regional blocks reduces the systemic anesthetic dose required and improves intra-op stability. Epidural anesthesia, peripheral nerve blocks, dental nerve blocks for veterinary dental procedures, and incisional infiltration all have a place. The anesthetic premedication protocols framework integrates with the cardiac-specific approach to keep the systemic depressant load as low as possible.

Post-Operative and Recovery Considerations

Cardiac patients are at risk for post-operative complications including hypotension, arrhythmia, pulmonary edema (if fluid balance was generous), and delayed recovery. Continuous monitoring extends well past extubation. Pain management uses opioids and NSAID combinations carefully — NSAIDs are generally acceptable in stable cardiac patients with normal renal function, but cardiac patients on diuretics need monitoring for renal effects.

Resumption of routine cardiac medications post-operatively is part of the discharge plan. Some patients return to their full medication schedule the evening of surgery; others have a brief medication hold based on the procedure.

When to Defer Elective Anesthesia

Not every cardiac patient should have elective anesthesia at the time it is first considered. Conditions that often warrant deferral:

• Stage C or D heart failure in an unstable phase
• Uncontrolled arrhythmia (sustained ventricular tachycardia, uncontrolled atrial fibrillation)
• Active pulmonary edema
• Recent thromboembolic event
• Recent decompensation requiring hospitalization

The cardiology team and anesthesia team jointly assess whether optimization can reach a more stable plane before the procedure, or whether the procedure itself is urgent enough to proceed at higher risk. Emergent surgery in active CHF is sometimes unavoidable; planned elective procedures usually can wait for optimization.

Cost and Access Reality

Anesthesia by a DACVAA is significantly more expensive than anesthesia by a primary veterinarian or technician-led anesthesia program. The added safety margin matters for high-risk cardiac patients and elective procedures should be planned with the specialty support if the patient’s cardiac status warrants it. In regions without DACVAA access, telemedicine anesthesia consultation by experienced specialists is increasingly available and can support the primary team through a high-risk case.

Cost-benefit for owners typically falls in favor of the specialty support for the highest-risk patients (HCM cats with LVOTO, DCM Dobermans with arrhythmia, advanced MVD dogs needing dental work). For lower-risk Stage B1 patients, primary care anesthesia with the standard monitoring stack and a careful drug plan is often appropriate.

Adoption Perspective

Cardiac patients in rescue and shelter populations frequently need anesthesia for dental disease, mass removal, or spay/neuter. The adoption-positive framing is: cardiac diagnoses are not refusals for these procedures, but they are care plans requiring thoughtful pre-procedure assessment, specialty input where available, and realistic expectations from adopters about the modestly elevated procedural risk. Many cardiac patients tolerate well-planned anesthesia smoothly and benefit substantially from the procedure being done.

Frequently Asked Questions

Is anesthesia safe for my pet with a heart murmur?

Most stable cardiac patients tolerate well-planned anesthesia with appropriate monitoring. The risk depends on the underlying disease, stage, and procedure type. A Stage B1 MVD dog with no clinical signs typically does well with primary-care anesthesia plus standard monitoring. Higher-risk patients benefit from DACVAA specialty support.

Why is ketamine avoided in HCM cats?

Ketamine’s sympathomimetic effects increase heart rate, contractility, and outflow tract obstruction in HCM with LVOTO. These changes can precipitate arrhythmia and sudden death. Combination protocols (e.g., ketamine with benzodiazepine and opioid) may be used in some specific cases, but ketamine alone is contraindicated in HOCM.

Should my pet’s cardiac medications be continued before anesthesia?

Most cardiac medications continue through the perioperative period. Pimobendan, furosemide, ACE inhibitors, beta-blockers, and anti-arrhythmics are usually maintained. The anesthesia team may adjust timing of doses or skip a specific dose based on the patient’s hemodynamic plan.

What is the role of NT-proBNP before anesthesia?

Selectively useful in patients with suspected occult cardiac disease (Doberman DCM screening, asymptomatic murmur of unclear severity). A normal NT-proBNP in a clinically normal pet provides additional reassurance. The biomarker does not replace echocardiography in patients with known cardiac disease.

Can pacemaker patients have routine anesthesia?

Yes, with continuous ECG monitoring and electrocautery shielding. Pre-procedure interrogation of the device is recommended. The pacing system protects the patient from bradyarrhythmia, but standard cardiac anesthesia monitoring still applies.